AllNewsVideos'Dr Reddys' - 598 News Result(s)Andhra Chief Minister Unveils World's Largest Statue Of BR AmbedkarIndia News | Asian News International | Saturday January 20, 2024 In a significant move towards promoting inclusivity and honouring the contributions of BR Ambedkar, Andhra Pradesh Chief Minister YS Jagan Mohan Reddy on Friday unveiled the statue of Dr BR Ambedkar in Vijayawada. www.ndtv.comSensex, Nifty End At New All-Time Highs, Sustain Momentum For 6th DayBusiness | Press Trust of India | Tuesday November 29, 2022 Among the Sensex pack, Hindustan Unilever, Sun Pharma, Nestle, Dr Reddy's, Tata Steel, ICICI Bank, Titan and HCL Technologies were the major winners. www.ndtv.com/businessAntitrust Litigation Filed Against Dr Reddy's Laboratories In USBusiness | Press Trust of India | Tuesday November 22, 2022 Dr Reddy's Laboratories Ltd on Tuesday said it is among several generic pharmaceutical companies, including Celgene and Bristol Myers Squibb, against which an antitrust litigation has been filed in the US. www.ndtv.com/businessDr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, InjectablesBusiness | Press Trust of India | Sunday November 6, 2022 Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses. www.ndtv.com/businessDr Reddy's, Cipla, Aurobindo Units Recall Products From US MarketBusiness | Press Trust of India | Sunday October 23, 2022 Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration. www.ndtv.com/businessSupreme Court Rejects Pleas Challenging 'Proposer' Requirement In President PollIndia News | Press Trust of India | Wednesday June 29, 2022 A vacation bench comprising justices Surya Kant and JB Pardiwala was hearing separate pleas filed by Delhi resident Bam Bam Maharaj Nowhattia and Dr Mandati Thirupathi Reddy, a native of Prakasam district in Andhra Pradesh, on the issue. www.ndtv.comStocks To Watch: Zomato, Adani Enterprises, Infosys, Dr Reddy'sBusiness | Edited by Prashun Talukdar | Monday June 27, 2022 The domestic stock indices are likely to trade higher on Monday, taking cues from their global peers. www.ndtv.com/businessInvestors Lose More Than Rs 6.47 Lakh Crore As Markets FallBusiness | Press Trust of India | Tuesday June 7, 2022 Investors' wealth on Tuesday tumbled over Rs 2 lakh crore amid heavy selling pressure in domestic equities www.ndtv.com/businessDr Reddy's Plans 'Business Continuity' In RussiaBusiness | Reuters | Wednesday March 9, 2022 Indian pharmaceutical major Dr. Reddy's Laboratories Ltd said on Wednesday it was focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from Russia in recent days. www.ndtv.com/businessDr Reddy's Laboratories Gets FDA Approval, Launches Drug In US MarketIndia News | Press Trust of India | Wednesday February 9, 2022 Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market. www.ndtv.comProposal For Sputnik Light As Covid Booster Submitted To Drug RegulatorIndia News | Press Trust of India | Monday February 7, 2022 Drug major Dr Reddy's Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against COVID-19, a top company official has said. www.ndtv.comTrying To Bring Vaccine For 12-18 Age Group To India: Dr Reddy'sIndia News | Press Trust of India | Friday January 28, 2022 Dr Reddy's Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia's Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India. www.ndtv.comSensex Tanks Over 700 Points, Nifty Trades Below 17,550; Tech Mahindra, Bajaj Finserv, Dr Reddy's Among Top DragsBusiness | Edited by Prashun Talukdar | Friday January 21, 2022 The Indian equity benchmarks continued to plunge for the fourth straight session on Friday amid weak global cues. www.ndtv.com/businessStocks To Watch: Airtel, Future Retail, GAIL India, Dr Reddy'sBusiness | Edited by Prashun Talukdar | Wednesday January 5, 2022 The domestic stock indices are likely to trade lower on Wednesday taking cues from the global markets. www.ndtv.com/businessMerck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In IndiaIndia News | Reuters | Tuesday January 4, 2022 Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir. www.ndtv.comMore News »'Dr Reddys' - 12 Video Result(s)Sputnik V Shot To Cost Rs. 750, To Arrive By May-June: Dr Reddy's To NDTVApr 21, 20218:43Sell Dr Reddy's Labs With Stop Loss At Rs 3,090: Manas JaiswalJan 9, 20179:52Support For Nifty Around 7,500-7,600: Sanjiv BhasinApr 28, 201625:15Buy Dr Reddy's Lab on Declines: Mayuresh JoshiNov 19, 201516:40Positive on Dr Reddy's Laboratories: Sanjiv BhasinNov 10, 201515:33Buy Dr Reddy's Laboratories on Declines: Equinomics ResearchNov 6, 201510:33Generic Nexium to Boost Dr Reddy's Bottlomline: Surjit PalSep 28, 201510:31Bullish on Adani Port, Ashok Leyland: Religare SecuritiesMar 29, 201222:56Earnings review: DRLJul 23, 20108:18GSK ties up with Dr Reddy'sJun 16, 20092:11M&A should pick up in Indian pharma space: CentrumMar 13, 20093:29Dr Reddy's: Buy or sellFeb 27, 20091:35'Dr Reddys' - 598 News Result(s)Andhra Chief Minister Unveils World's Largest Statue Of BR AmbedkarIndia News | Asian News International | Saturday January 20, 2024 In a significant move towards promoting inclusivity and honouring the contributions of BR Ambedkar, Andhra Pradesh Chief Minister YS Jagan Mohan Reddy on Friday unveiled the statue of Dr BR Ambedkar in Vijayawada. www.ndtv.comSensex, Nifty End At New All-Time Highs, Sustain Momentum For 6th DayBusiness | Press Trust of India | Tuesday November 29, 2022 Among the Sensex pack, Hindustan Unilever, Sun Pharma, Nestle, Dr Reddy's, Tata Steel, ICICI Bank, Titan and HCL Technologies were the major winners. www.ndtv.com/businessAntitrust Litigation Filed Against Dr Reddy's Laboratories In USBusiness | Press Trust of India | Tuesday November 22, 2022 Dr Reddy's Laboratories Ltd on Tuesday said it is among several generic pharmaceutical companies, including Celgene and Bristol Myers Squibb, against which an antitrust litigation has been filed in the US. www.ndtv.com/businessDr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, InjectablesBusiness | Press Trust of India | Sunday November 6, 2022 Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses. www.ndtv.com/businessDr Reddy's, Cipla, Aurobindo Units Recall Products From US MarketBusiness | Press Trust of India | Sunday October 23, 2022 Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration. www.ndtv.com/businessSupreme Court Rejects Pleas Challenging 'Proposer' Requirement In President PollIndia News | Press Trust of India | Wednesday June 29, 2022 A vacation bench comprising justices Surya Kant and JB Pardiwala was hearing separate pleas filed by Delhi resident Bam Bam Maharaj Nowhattia and Dr Mandati Thirupathi Reddy, a native of Prakasam district in Andhra Pradesh, on the issue. www.ndtv.comStocks To Watch: Zomato, Adani Enterprises, Infosys, Dr Reddy'sBusiness | Edited by Prashun Talukdar | Monday June 27, 2022 The domestic stock indices are likely to trade higher on Monday, taking cues from their global peers. www.ndtv.com/businessInvestors Lose More Than Rs 6.47 Lakh Crore As Markets FallBusiness | Press Trust of India | Tuesday June 7, 2022 Investors' wealth on Tuesday tumbled over Rs 2 lakh crore amid heavy selling pressure in domestic equities www.ndtv.com/businessDr Reddy's Plans 'Business Continuity' In RussiaBusiness | Reuters | Wednesday March 9, 2022 Indian pharmaceutical major Dr. Reddy's Laboratories Ltd said on Wednesday it was focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from Russia in recent days. www.ndtv.com/businessDr Reddy's Laboratories Gets FDA Approval, Launches Drug In US MarketIndia News | Press Trust of India | Wednesday February 9, 2022 Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market. www.ndtv.comProposal For Sputnik Light As Covid Booster Submitted To Drug RegulatorIndia News | Press Trust of India | Monday February 7, 2022 Drug major Dr Reddy's Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against COVID-19, a top company official has said. www.ndtv.comTrying To Bring Vaccine For 12-18 Age Group To India: Dr Reddy'sIndia News | Press Trust of India | Friday January 28, 2022 Dr Reddy's Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia's Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India. www.ndtv.comSensex Tanks Over 700 Points, Nifty Trades Below 17,550; Tech Mahindra, Bajaj Finserv, Dr Reddy's Among Top DragsBusiness | Edited by Prashun Talukdar | Friday January 21, 2022 The Indian equity benchmarks continued to plunge for the fourth straight session on Friday amid weak global cues. www.ndtv.com/businessStocks To Watch: Airtel, Future Retail, GAIL India, Dr Reddy'sBusiness | Edited by Prashun Talukdar | Wednesday January 5, 2022 The domestic stock indices are likely to trade lower on Wednesday taking cues from the global markets. www.ndtv.com/businessMerck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In IndiaIndia News | Reuters | Tuesday January 4, 2022 Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir. www.ndtv.comMore News »'Dr Reddys' - 12 Video Result(s)Sputnik V Shot To Cost Rs. 750, To Arrive By May-June: Dr Reddy's To NDTVApr 21, 20218:43Sell Dr Reddy's Labs With Stop Loss At Rs 3,090: Manas JaiswalJan 9, 20179:52Support For Nifty Around 7,500-7,600: Sanjiv BhasinApr 28, 201625:15Buy Dr Reddy's Lab on Declines: Mayuresh JoshiNov 19, 201516:40Positive on Dr Reddy's Laboratories: Sanjiv BhasinNov 10, 201515:33Buy Dr Reddy's Laboratories on Declines: Equinomics ResearchNov 6, 201510:33Generic Nexium to Boost Dr Reddy's Bottlomline: Surjit PalSep 28, 201510:31Bullish on Adani Port, Ashok Leyland: Religare SecuritiesMar 29, 201222:56Earnings review: DRLJul 23, 20108:18GSK ties up with Dr Reddy'sJun 16, 20092:11M&A should pick up in Indian pharma space: CentrumMar 13, 20093:29Dr Reddy's: Buy or sellFeb 27, 20091:35Your search did not match any documentsA few suggestionsMake sure all words are spelled correctlyTry different keywordsTry more general keywordsCheck the NDTV Archives:https://archives.ndtv.com